Instil Bio, Inc. (NasdaqCM: TIL)
Health Care · Biotechnology · US
$5.91
-12.31% today · -70.7% 1Y
Instil Bio, Inc. (NasdaqCM: TIL) operates in the Biotechnology industry within the Health Care sector. The company is valued at $40.08M and employs 17 people.
Over the last twelve months the share price has lost 70.7%, trading between 5.67 and 20.33.
Tweenvest scores Instil Bio, Inc. across four factors: quality 58/100, value 36/100. Its strongest factor is quality.
TIL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $40.08M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -4.47
- Dividend yield
- —
- Beta (5Y)
- 1.94
- 52-week high
- $20.33
- 52-week low
- $5.67
- Avg volume (3M)
- —
- Shares outstanding
- 6.78M
- Employees
- 17
- Next earnings
- —
About Instil Bio, Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
- ISIN
- US45783C2008
- Founded
- 2018
- Listed since
- Mar 19, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| KoBioLabs, IncKOSDAQ: A348150 | $40.93M | ₩2,810.00 | -2.43% |
| Cutia TherapeuticsSEHK: 2487 | $40.89M | HK$0.86 | +0.58% |
| NurExone Biologic Inc.TSXV: NRX | $40.89M | CA$0.60 | -3.33% |
| TegoScience Inc.KOSDAQ: A191420 | $40.24M | ₩6,700.00 | -5.63% |
| Genomics BioSci & Tech. Co.,Ltd.TWSE: 4195 | $38.71M | NT$15.70 | -3.68% |
| ME Therapeutics Holdings Inc.CNSX: METX | $38.53M | CA$1.80 | -35.71% |
| J2KBIO Co., Ltd.KOSDAQ: A420570 | $38.16M | ₩8,700.00 | -8.52% |
| TMS Co., Ltd.TSE: 4891 | $38.05M | ¥131.00 | +1.55% |
Figures last refreshed Oct 18, 2026.